← Back to Search

Balance Tele-Rehab for Parkinson's Disease

N/A
Recruiting
Led By Laurie A King, PhD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre and post rehabilitation
Awards & highlights
No Placebo-Only Group

Summary

This trial will study if remote monitoring and treatment of balance issues in people with Parkinson's can be effective. #medicine #Parkinsons

Who is the study for?
This trial is for people aged 55-85 with Parkinson's disease who can follow directions and participate in exercise. They should be responsive to levodopa, at stages I-III of the disease, and able to commit to a rehab program 3 times a week for 4 weeks without changing medications or other exercises.
What is being tested?
The study tests the effectiveness of Balance Tele-Rehabilitation Agility Boot Camp (ABC) delivered remotely for improving balance in Parkinson's patients. It aims to assess if this method is feasible as a treatment option.
What are the potential side effects?
Since this intervention involves physical exercise, potential side effects may include muscle soreness, fatigue, and an increased risk of falls during activities. However, specific side effects will depend on individual health conditions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre and post rehabilitation
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre and post rehabilitation for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline in the Mini-BESTest, a 14-item test of 4 domains of balance post-rehabilitation
Secondary study objectives
360 Degree Turn Test
Activities-Specific Balance Confidence
Change from Baseline in the Patient Global Impression of Change (PGIC), a seven point scale depicting the patient's impression of improvement post-rehabilitation
+13 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Supervised Tele-Rehabilitation Home ExerciseExperimental Treatment1 Intervention
40 participants will have tele-rehabilitation virtually with a physical therapist for 60 minutes approximately three times per week for four weeks of intervention (12 visits). Participants will also be assessed for daily life mobility for seven days pre and post intervention with wearable sensors.
Group II: Unsupervised Rehabilitation Home ExerciseActive Control1 Intervention
40 participants will complete their home exercise Agility Boot Camp (ABC) program for 60 minutes approximately three times per week for four weeks of intervention (12 sessions). Participants will also be assessed for daily life mobility for seven days pre and post intervention with wearable sensors.

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
1,008 Previous Clinical Trials
7,414,109 Total Patients Enrolled
14 Trials studying Dementia
1,564 Patients Enrolled for Dementia
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,067 Previous Clinical Trials
2,747,643 Total Patients Enrolled
Laurie A King, PhDPrincipal InvestigatorOregon Health and Science University
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

Balance Tele-Rehabilitation Agility Boot Camp (ABC) Clinical Trial Eligibility Overview. Trial Name: NCT05680597 — N/A
Dementia Research Study Groups: Supervised Tele-Rehabilitation Home Exercise, Unsupervised Rehabilitation Home Exercise
Dementia Clinical Trial 2023: Balance Tele-Rehabilitation Agility Boot Camp (ABC) Highlights & Side Effects. Trial Name: NCT05680597 — N/A
Balance Tele-Rehabilitation Agility Boot Camp (ABC) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05680597 — N/A
~41 spots leftby Jun 2027